Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.

Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2021)

An integral role of IL-33 in the pathogenesis of allergic and nonallergic airway inflammatory disease is evident with several emerging clinical trials investigating therapeutic approaches. Current data support a critical role of IL-33 in damage signaling, repair and regeneration of lungs.

Keyphrases

clinical trial
oxidative stress
stem cells
chronic obstructive pulmonary disease
allergic rhinitis
big data
cystic fibrosis
phase ii
deep learning
air pollution
phase iii